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Panduratin A (1) is the prototypical member of a family of related 
cyclohexenyl natural products and is isolated as a racemic mixture 
from Boesenbergia rotunda, a perennial herb found in South East 
Asia (Figure 1).[1–4] The plant has been used in traditional 
medicine to treat conditions such as diarrhea, asthma, indigestion, 
dysentery and many others.[1–4] More recently studies have shown 
that these extracts have anti-HIV, anti-bacterial, anti-fungal and 
anti-tumor activity.[3–6] Our particular interest in panduratin A (1) 
and its congeners stems from a report that they competitively 
inhibit the dengue virus NS2B-NS3 protease.[7,8] Herein we report 
the synthesis of panduratin A (1) in 6 steps via a high pressure 
Diels–Alder reaction. This divergent sequence has also allowed 
for the synthesis of the related natural products 
4-hydroxypanduratin A (2), panduratin H (3), panduratin I (4), 
nicolaioidesin B (5) and 2-hydroxyisopanduratin A (6). [1–9] We 
investigated the binding of 4-hydroxypanduratin A (2) to the 
dengue virus NS2B-NS3 protease by NMR spectroscopy. 
To date two syntheses of panduratin A (1) have been 
reported,[10,11] both of which employed a cycloaddition reaction 
between a protected chalcone derivative 7 and E-ocimene (8) 
(Scheme 1). The first reported synthesis by Rahman and 
co-workers[10] in 2010 was achieved by a thermally promoted 
Diels–Alder reaction between chalcone derivative 7 (P = MEM) 
and E-ocimene (8) followed by deprotection to afford a mixture of 
panduratin A and its regioisomer nicolaioidesin B. No 
regioisomer ratio was reported for this mixture, nor were the 
regioisomers separated. In the same year Porco and co-workers[11] 
employed a silver nanoparticle catalyst developed in their 
laboratory to facilitate the cycloaddition between a chalcone 7 (P 
= Ac) and E-ocimene (8). This methodology afforded the adduct 
leading to panduratin A (1) with a small amount of the exo isomer 
corresponding to the isomeric natural product nicolaioidesin A. 
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Figure 1. Panduratin A (1) and related natural products. 
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Scheme 1. Rahman[10] and Porco[11] synthetic strategy and retrosynthetic analysis for 
this work. 
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These efforts serve to highlight two key issues encountered in 
synthetic strategies targeting the panduratin natural product 
family. Firstly, the requisite chalcones are typically poor 
dienophiles in the Diels–Alder reaction due to their high level of 
substitution and moderate activation and require forcing 
conditions or special techniques to achieve high yields. Secondly, 
the diene E-ocimene (8) is known to be sensitive to Brønsted and 
Lewis acids resulting in polymerization and alkene 
isomerization.[12] We instead envisaged an early stage high 
pressure Diels–Alder reaction[13] to construct the cyclohexene 
core employing a sterically less encumbered and more active 
dienophile such as methyl cinnamate 9 with E-ocimene (8), 
followed by the construction of the phenylmethanone sidechain 
through organometallic addition (Scheme 1). This approach 
allows for late-stage access to different members of the 
panduratin family and is modular thereby providing avenues for 
the synthesis of analogues through the variation of building 
blocks. 
The synthesis of panduratin A (1) began with the Diels–Alder 
cycloaddition of methyl cinnamate 9 and E-ocimene (8, see 
Supporting Information) performed under high pressure 
conditions (19 kbar) to afford the regioisomeric panduratin H (3) 
and I (4) in a 1:2.9 ratio (Scheme 2). Employing thermal 
conditions or Lewis acids failed to afford the Diels–Alder  
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Scheme 2. Synthesis of panduratin A (1) and 4-hydroxypanduratin A (2). 
adduct. A combination of flash chromatography and HPLC 
separation afforded pure regioisomers that conformed to the 
reported literature data.[4] In both isomers the orientation of the 
prenyl sidechain was cis to the adjacent ring substituent. Hydride 
reduction gave the alcohol products 10 and 11 that were readily 
separated by flash column chromatography, thus providing 
intermediates with the correct relative stereochemistry for the 
synthesis of panduratin A (1) and regioisomeric natural products. 
Subsequent oxidation of alcohol 10 with Dess–Martin periodinane 
provided aldehyde 12 as the branching point towards either 
panduratin A (1) or 4-hydroxypanduratin A (2). Addition of the 
organolithium reagent derived from bromobenzene 13 followed 
by Dess–Martin periodinane oxidation gave MOM protected 
ketone 14. Removal of the MOM groups with acidic methanol 
cleanly afforded panduratin A (1). Using alternate bromobenzene 
15 and following the same synthetic sequence via ketone 16 gave 
4-hydroxypanduratin A (2) in a yield of 52% over 3 steps. The 
spectroscopic data for panduratin A (1) and 4-hydroxypanduratin 
A (2) agreed with that of literature.[1,2] 
To further explore the influence of structure on cycloaddition 
regioselectivity, various dienophiles 17 with differing electronic 
and steric attributes were paired with E-ocimene (8) in the high 
pressure Diels–Alder reaction (Table 1). After reaction the 
products were reduced to the corresponding alcohol or aldehyde 
which were easily separated and purified by flash column 
chromatography. In all cases the reactions afforded regioisomer B 
as the major product. Stronger activating groups such as the 
aldehyde or nitrile provided slightly higher ratios favouring 
regioisomer B. However, substitution of the ethyl ester for the 
more electron withdrawing 2,2,2-trifluoroethyl ester, a strong 
inductive electron withdrawing group, provided Diels–Alder 
adducts in a similar ratio.[14,15] 
Table 1. High pressure Diels–Alder reactions of different dienophiles 17 with 
E-ocimene (8). 
X
Ph
X
Ph
X
Ph
8, 19 kbar 
DCM, RT, 3 d
A B17  
X Yield [%] Ratio A:B[a] 
CN 64[b] 1:9.5 
COOtBu 63[c] 1:8.9 
CHO 62 1:7.2 
COOEt 68[c] 1:3.1 
COOMe 73[c] 1:2.9 
COOCH2CF3 56[c] 1:2.4 
[a] Ratio of regioisomers determined by 400 MHz 1H NMR integration of the 
crude reaction mixture. [b] After reduction to aldehyde. [c] After reduction to 
alcohol. 
The regiochemical outcome of the Diels–Alder cycloaddition 
between methyl cinnamate (9) with E-ocimene (8) was in accord 
with an analysis based on computationally-derived frontier 
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molecular orbitals (Figure 2). Alignment of the larger diene 
HOMO (2Pz atomic) coefficient with that of the corresponding 
dienophile LUMO coefficient predicts formation of ester 4 as the 
major regioisomer.[16] Orbital coefficients also predict the correct 
regiochemical outcomes for the other compounds studied in Table 
1 (see the Supporting Information for further details). 
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9 8  
Figure 2. Atomic orbital coefficients of the 2p orbitals of methyl cinnamate (9), and 
E-ocimene (8) calculated at the B3LYP/6-31G(d) level of theory (see computational 
methods in the Supporting Information for further details). 
Employing cinnamaldehyde (18) in the high pressure Diels–
Alder reaction afforded a separable 1:7.2 mixture of the two 
Diels–Alder regioisomers 12 and 19 (Scheme 3). Addition of the 
organolithium reagent derived from bromobenzene 13 to aldehyde 
19 followed by oxidation afforded ketone 20 in 69% over two 
steps. Deprotection gave nicolaioidesin B (5) in 69% yield.[9] 
Using alternate bromobenzene 15 and following the same 
synthetic sequence via ketone 21 gave 4-hydroxyisopanduratin A 
(6) in a yield of 50% over 3 steps. The spectroscopic data for 
nicolaioidesin B (5) and 4-hydroxyisopanduratin A (6) agreed 
with that of literature.[3,9] 
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Scheme 3. Synthesis of nicolaioidesin B (5) and 4-hydroxyisopanduratin A (6). 
The dengue virus NS2B-NS3 protease is crucial for viral 
replication and presents a target for the treatment of dengue virus 
infections. The hydrophilic NS2B fragment acts as a cofactor 
essential for full proteolytic activity. Recent NMR studies in 
association with pseudocontact shifts derived from paramagnetic 
lanthanide tags have shown that binding of an inhibitor at the 
substrate-binding site can trigger a large conformational change of 
the NS2B cofactor, shifting the protein structure from an open to a 
closed conformation.[17] Crystal structures of the NS2B-NS3 
protease with bound inhibitors show that in the closed 
conformation, which is also thought to be the active conformation, 
NS2B lines the substrate binding site.[18] 
Both panduratin A (1) (Ki = 25 ± 8 µM) and 
4-hydroxypanduratin A (2) (Ki = 21 ± 6 µM) have been reported, 
based on enzyme kinetic data, to inhibit the dengue virus NS2B-
NS3 protease competitively, identifying them as important natural 
product lead structures.[7,8] Thus NMR spectroscopy suggested 
itself as a suitable method to further define the nature of binding 
of these natural products at the NS2B-NS3 protease. To test 
whether panduratins can induce a closed conformation we 
recorded 15N-HSQC spectra of the uniformly 15N-labelled NS2B-
NS3 protease in the presence and absence of the compounds. No 
changes to the spectrum NS2B-NS3 protease were observed in the 
presence of panduratin A (1) or 4-hydroxypanduratin A (2), in 
contrast to the response to previously reported low molecular 
weight competitive inhibitors.[17] Previous NMR and X-ray data 
showed, that binding of inhibitors at the substrate binding site can 
stabilize a closed conformation of the protease that resembles the 
enzymatically active state.[17,18] The NMR spectra obtained in the 
presence of either panduratin A (1) or 4-hydroxy-panduratin A (2) 
showed no evidence for such a conformational change. In our 
hands, panduratin A (1) and 4-hydroxypanduratin A (2) also 
proved to be poorly soluble in aqueous media. Addition of either 
of the two compounds from DMSO stock solutions to the protein 
sample caused precipitation of the panduratins. Panduratin A (1) 
precipitated even at a target concentration of 100 µM in 15% 
aqueous DMSO. These results highlight that some caution is 
warranted in adopting panduratin A (1) and 4-hydroxypanduratin 
A (2) as lead structures for the development of dengue virus 
NS2B-NS3 protease inhibitors. 
In conclusion we have completed the synthesis of panduratin 
A (1) and five related natural products 2–6 using a high pressure 
Diels–Alder reaction as the key step. This flexible route provides 
rapid access to various members of the natural product family and 
is amenable to analogue synthesis. However, attempts to monitor 
the binding of panduratin A (1) and 4-hydroxypanduratin A (2) to 
the dengue virus NS2-NS3 protease by NMR failed to show the 
characteristic changes in protein conformation that have been 
observed for other known competitive inhibitors. 
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Chemistry Experimental 
General 
Infrared absorption (IR) spectra were obtained using with a Perkin–Elmer Spectrum One FTIR 
spectrometer. Compounds were prepared as a thin film between 0.5 cm sodium chloride plates. 
Absorption maxima (νmax) are expressed in wavenumbers (cm–1). 1H Nuclear magnetic resonance 
spectra were recorded using a Varian Mercury 300 (300 MHz), Varian Mercury 400 (400 MHz) or 
Bruker 800 (800 MHz) spectrometer at 25°C, and are recorded in parts per million (ppm) 
downfield shift from tetramethylsilane (δTMS = 0), using residual chloroform (δ 7.26) or methanol (δ 
3.31) solvent as internal reference. The data is reported as chemical shift (δH), relative integral, 
multiplicity (s = singlet, br = broad, d = doublet, t = triplet, q = quartet, m = multiplet), coupling 
constant (J Hz), and assignment. 13C Nuclear magnetic resonance spectra were recorded using a 
Varian Mercury 300 (75 MHz) or Varian Mercury 400 (100 MHz) spectrometer at 25°C with 
complete proton decoupling. Data is expressed in parts per million (ppm) downfield relative to 
tetramethylsilane (δTMS = 0) using deuterated chloroform (δ 77.00) solvent as an internal reference 
and is reported as chemical shift (δC). High and low resolution electron impact ionization (EI) mass 
spectra were recorded using a Micromass VG Autospec mass spectrometer. Low and high 
resolution electrospray ionization (ESI) mass spectra were recorded using a Micromass ZMD LR 
mass spectrometer or a Waters LCT Premier XE mass spectrometer respectively. Preparative HPLC 
was performed on a Waters preparative HPLC system consisting of a 600E solvent delivery system, 
in-line degasser and 2996 diode array detector. Samples were injected manually via a Rheodyne 
7725i injection valve fitted with a 5 mL loop and separated on a Waters XBridge C18 5 µm 150 
mm × 4.6 mm eluted at 1 mL min–1. The system was interfaced with Empower 2 software for 
instrument control and data acquisition. Analytical thin layer chromatography (TLC) was performed 
using 0.2 mm thick aluminum backed pre-coated silica gel plates (Merck Kieselgel 60 F254). Flash 
chromatography was carried out using Merck Kieselgel 60 (230–400 mesh ASTM), under a positive 
pressure of nitrogen. Solvent compositions were mixed v/v as specified. High pressure reactions 
were carried out in a PSIKA high pressure reactor. All solvents and reagents were purified 
according to standard literature procedures.[1] 
 
3-Methyl-2-(3-methylbut-2-en-1-yl)-2,5-dihydrothiophene 1,1-dioxide (22)[2] 
 
3-Methyl sulfolene (3.46 g, 26.2 mmol), prenyl bromide (1.53 mL, 13.1 mmol) and tetrahydrofuran 
(50 mL) were added to a flask and under a nitrogen atmosphere and cooled to –95°C with stirring. 
S3
 
 
LHMDS (26.2 mL, 1 M, 26.2 mmol) in tetrahydrofuran was then slowly added over 1 min and the 
reaction allowed to stir for a further 1 min. Quenching with a saturated solution of ammonium 
chloride (30 mL) was then followed by extraction with diethyl ether (3 × 20 mL). The combined 
organic layers were then dried over magnesium sulfate, filtered, concentrated under reduced 
pressure and purified via silica gel chromatography using diethyl ether : hexane (2:3) to afford 3-
methyl-2-(3-methylbut-2-en-1-yl)-2,5-dihydrothiophene 1,1-dioxide 22 as a clear yellow oil (2.15 g, 
82%); Rf (diethyl ether:hexane 2:3) 0.19; 1H-NMR (400 MHz, CDCl3) δ 5.68 (1H, m, H4), 5.21 
(1H, m, H2'), 3.73–3.60 (2H, m, H5), 3.50 (1H, t, J = 6.0 Hz, H2), 2.61–2.49 (2H, m, H1'), 1.85 (3H, 
s, CH3), 1.72 (3H, s, CH3), 1.66 (3H, s, CH3); 13C-NMR (100 MHz, CDCl3) δ 138.6, 135.3, 118.3, 
117.0, 67.2, 55.6, 26.4, 25.7, 18.1, 17.8; IR (thin film) νmax = 2970 (m), 2920 (m), 2856 (m), 1730 
(w), 1671 (w), 1442 (m) 1380 (m), 1303 (s) cm–1; LRMS (EI+) m/z = 200 (M+•, 10%), 135 ([M–
SO2–H]+•, 100%); HRMS (EI+) calcd for C10H16O2S (M+•) 200.0871, found 200.0873, calcd for 
C10H15 ([M–SO2H]+•) 135.1174, found 135.1172. 
 
(E)-Ocimene (8)[2] 
 
3-Methyl-2-(3-methylbut-2-en-1-yl)-2,5-dihydrothiophene 1,1-dioxide 22 (403 mg, 2.01 mmol) and 
pyridine (20 mL) were added to a flask and heated at reflux for 6 hours with stirring. After cooling 
to room temperature the reaction was extracted with 30–40 petroleum spirits (20 mL) and washed 
with 2 M hydrochloric acid solution (4 × 20 mL). The petroleum spirit layer was then washed 
through a silica gel plug and concentrated under reduced pressure to give E-ocimene 8 as a clear 
colorless oil (222 mg, 81%); Rf (diethyl ether:hexane 2:3) 0.75; 1H-NMR (300 MHz, CDCl3) δ 6.37 
(1H, dd, J = 17.4 & 11.1 Hz, H3), 5.46 (1H, t, J = 7.8 Hz, H5), 5.16–5.07 (2H, m, H2 & H7), 4.94 
(1H, d, J = 10.5 Hz, H1), 2.84 (2H, t, J = 7.5 Hz, H6), 1.77 (3H, s, CH3), 1.71 (3H, s, CH3), 1.65 
(3H, s, CH3); 13C-NMR (75 MHz, CDCl3) δ 141.6, 133.8, 132.3, 131.9, 122.3, 110.7, 27.4, 25.8, 
17.8, 11.7; IR (thin film) νmax = 2975 (s), 2926 (s), 2857 (m), 1789 (w), 1640 (m), 1606 (m), 1448 
(m), 1376 (m) cm–1; LRMS (EI+) m/z = 136 (M+•, 45%), 93 (100%). 
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(±)-Panduratin H (3) and (±)-panduratin I (4)[3] 
 
Methyl cinnamate 9 (601 mg, 3.71 mmol), E-ocimene 8 (2.02 g, 14.8 mmol) and dichloromethane 
(2 mL) were added to a pressure vessel, sealed and pressurized to 19 kbar for 3 days. The reactions 
was then diluted with dichloromethane (20 mL), evaporated on to silica and purified by column 
chromatography using diethyl ether : hexane (1:9) and then preparative HPLC on Waters Xbridge 
C18, 60% acetonitrile, 40% water: to afford (Rt 31.1 min) (±)-panduratin H 3 as a clear colorless oil 
(257 mg, 23%); Rf (diethyl ether:hexane 1:4) 0.44; 1H-NMR (400 MHz, CDCl3) δ 7.26 (2H, m, 
H3''), 7.20–7.13 (3H, m, H2''& H4''), 5.42 (1H, br s, H4), 5.06 (1H, m, H2'), 3.40 (3H, s, OCH3), 
3.19 (1H, ddd, J = 12.0, 10.4 & 6.4 Hz, H6), 3.08 (1H, dd, J = 12.4, 4.8 Hz, H1), 2.45 (1H, dd, J = 
10.4 & 5.2 Hz, H2), 2.40–2.23 (2H, m, H5β & H1'a), 2.17 (1H, m, H1'b), 2.04 (1H, m, H5α), 1.78 
(3H, s, CH3), 1.67 (3H, s, CH3 ), 1.60 (3H, s, CH3); 13C-NMR (100 MHz, CDCl3) δ 173.8, 145.9, 
136.3, 132.0, 128.3, 127.1, 126.0, 123.8, 121.0, 51.0, 49.1, 42.6, 37.1, 35.1, 29.2, 25.9, 22.6, 17.9; 
IR (thin film) νmax = 2966 (m), 2949 (m), 2914 (m), 1741 (vs), 1494 (w), 1434 (m), 1301 (w), 
1157(s); LRMS (EI+) m/z = 298 (M+•, 60%), 169 (100%); HRMS (EI+) calcd for C20H26O2 (M+•) 
298.1933, found 298.1935. A further fraction from flash column chromatography gave (±)-
panduratin I 4 as a colorless oil (772 mg, 70%); Rf (diethyl ether:hexane 1:4) 0.39; 1H-NMR (400 
MHz, CDCl3) δ 7.26 (2H, m, H3''), 7.19–7.14 (3H, m, H2''& H4''), 5.45 (1H, br s, H4), 4.81 (1H, m, 
H2'), 3.49 (3H, s, OCH3), 3.33 (1H, dd, J = 11.2 & 5.2 Hz, H1), 3.18 (1H, ddd, J = 11.2, 9.6 & 6.4 
Hz, H6), 2.44 (1H, m, H5β), 2.32 (1H, m, H5α), 2.23 (1H, dd, J = 10.8 & 5.2 Hz, H2), 1.99–1.86 
(2H, m, H1'), 1.74 (3H, s, CH3), 1.57 (3H, s, CH3), 1.34 (3H, s, CH3); 13C-NMR (100 MHz, CDCl3) 
δ 176.5, 142.3, 137.6, 131.0, 128.2, 128.1, 126.1, 123.4, 119.5, 51.5, 46.3, 44.5, 39.9, 29.5, 27.6, 
25.8, 22.9, 17.7; IR (thin film) νmax = 2966 (m), 2950 (m), 2913 (m), 1739 (vs), 1496 (w), 1435 (m), 
1265 (m), 1162 (s); LRMS (EI+) m/z = 298 (M+•, 60%), 169 (100%); HRMS (EI+) calcd for 
C20H26O2 (M+•) 298.1933, found 298.1935. 
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(±)-((1R,2S,6R)-3-Methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl)methanol (10) 
and (±)-((1R,5S,6R)-4-methyl-5-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl)methanol 
(11) 
 
To a solution of panduratin H 3 and panduratin I 4 (251 mg, 0.841 mmol) in tetrahydrofuran (20 
mL) was added 1 M lithium aluminum hydride in tetrahydrofuran (3.37 mL, 3.37 mmol) dropwise 
over 5 minutes. After 1 h of stirring at room temperature the reaction was cooled to 0°C and ethyl 
acetate (10 mL) was added dropwise over 10 minutes. The reaction was then diluted with diethyl 
ether (80 mL) and a saturated solution of potassium sodium tartrate (80 mL) and stirred vigorously 
for 30 minutes. The diethyl ether layer was then separated and the aqueous layer re-extracted with 
diethyl ether (2 × 50 mL). The combined organic layers were washed with brine (50 mL) and 
evaporated on to silica with purification by column chromatography using diethyl ether : hexane 
(1:4) affording (3-methyl-2-(3-methylbut-2-en-1-yl)-6-phenyl-3-cyclohexene-1-yl)methanol 10 as a 
colorless oil (45.5 mg, 20%); Rf (diethyl ether:hexane 3:7) 0.20; 1H-NMR (400 MHz, CDCl3) δ 
7.27 (2H, m, H3'''), 7.20–7.17 (3H, t, J = 8.4 Hz, H2'''& H4'''), 5.45 (1H, br s, H4), 5.28 (1H, m, 
H2''), 3.38–3.26 (2H, m, H1'), 2.79 (1H, ddd, J = 10.8, 10.8 & 6.4 Hz, H6), 2.33–2.15 (6H, m, H1, 
H2 H5 & H1''), 1.78 (3H, s, CH3), 1.71 (3H, s, CH3), 1.68 (3H, s, CH3), (OH not observed); 
13C-NMR (100 MHz, CDCl3) δ 145.0, 137.2, 132.0, 128.5, 127.6, 126.3, 124.6, 121.2, 63.4, 45.0, 
40.5, 39.0, 34.9, 27.7, 25.8, 22.7, 18.0; IR (thin film) νmax = 3350 (m), 2963 (s), 2911 (s), 1602 (w), 
1452 (m), 1376 (w), 1048 (m), 757 (m); LRMS (ESI+) m/z = 293 ([M+Na]+, 58%), 102 (100%); 
HRMS (ESI+) calcd for C19H26ONa ([M+Na]+), 293.1881, found 293.1881. A second fraction 
afforded (4-methyl-5-(3-methylbut-2-en-1-yl)-6-phenylcyclohexa-3-en-1-yl)methanol 11 as a 
colorless oil (134 mg, 59%); Rf (diethyl ether:hexane 3:7) 0.15; 1H-NMR (400 MHz, CDCl3) δ 7.28 
(2H, m, H3'''), 7.20–7.16 (3H, m, H2'''& H4'''), 5.48 (1H, s, H3), 4.90 (1H, m, H2''), 3.60 (1H, m, 
H1'a), 3.42 (1H, m, H1'b), 2.92 (1H, dd, J = 9.6 & 4.8 Hz, H6), 2.36–2.24 (2H, m, H1 & H2a), 2.15 
(1H, m, H5), 2.06–1.99 (3H, m, H2b & H1''), 1.73 (3H, s, CH3), 1.58 (3H, s, CH3), 1.34 (3H, s, 
CH3), (OH not observed); 13C-NMR (100 MHz, CDCl3) δ 142.4, 137.1, 130.9, 129.3, 128.0, 126.0, 
123.6, 121.1, 66.1, 46.1, 44.1, 35.0, 28.1, 27.5, 25.8, 22.8, 17.7; IR (thin film) νmax = 3326 (m), 
2962 (s), 2913 (s), 1494 (m), 1452 (s), 1376 (m), 1032 (m), 703 (s); LRMS (ESI+) m/z = 293 
([M+Na]+, 100%); HRMS (ESI+) calcd for C19H26ONa ([M+Na]+), 293.1881, found 293.1884. 
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(±)-((1R,2S,6R)-3-Methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl)methanal (12) 
and (±)-((1R,5S,6R)-4-methyl-5-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl)methanal 
(19) 
 
Cinnamaldehyde 18 (917 mg, 6.94 mmol), E-ocimene 8 (3.79 g, 27.8 mmol) and dichloromethane 
(3 mL) were added to a pressure vessel, sealed and pressurized to 19 kbar for 3 days. The reactions 
was then diluted with dichloromethane (20 mL), evaporated on to silica and purified by column 
chromatography using diethyl ether : hexane (1:9) to afford as (3-methyl-2-(3-methylbut-2-en-1-yl)-
6-phenylcyclohex-3-en-1-yl)methanal 12 a clear colorless oil (144 mg, 8%); Rf (diethyl 
ether:hexane 1:4) 0.54; 1H-NMR (400 MHz, CDCl3) δ 9.46 (1H, d, J = 3.6 Hz, CHO), 7.28 (2H, m, 
H2''), 7.21–7.16 (3H, m, H3''& H4''), 5.49 (1H, br s, H4), 5.05 (1H, m, H2'), 3.35 (1H, ddd, J = 10.8, 
10.8 & 6.0 Hz, H6), 2.81 (1H, ddd, J = 10.8, 4.4 & 3.6 Hz, H1), 2.52–2.40 (2H, m, H2 & H5α), 
2.31 (2H, t, J = 5.6 Hz, H1'), 2.14 (1H, m, H5β), 1.78 (3H, s, CH3), 1.66 (3H, s, CH3), 1.60 (3H, s, 
CH3); 13C-NMR (100 MHz, CDCl3) δ 205.80, 144.0, 136.3, 132.3, 128.7, 127.7, 126.6, 123.7, 
121.6, 55.3, 42.2, 36.9, 34.0, 28.9, 25.7, 22.2, 18.0; IR (thin film) νmax = 2964 (m), 2914 (m), 1725 
(s), 1604 (w), 1493 (m), 1447 (m), 1209 (w), 748 (m); LRMS (EI+) m/z = 268 (M+•, 80%), 91 
(100%); HRMS (EI+) calcd for C19H24O (M+•) 268.1827, found 268.1824. A second fraction 
afforded (4-methyl-5-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl)methanal 19 as a clear 
colorless oil (630 mg, 54%); Rf (diethyl ether:hexane 1:4) 0.48; 1H-NMR (400 MHz, CDCl3) δ 9.42 
(1H, d, J = 3.6 Hz, CHO), 7.27 (2H, m, H3''), 7.20–7.16 (3H, m, H2''& H4''), 5.50 (1H, m, H3), 
4.85 (1H, m, H2'), 3.35 (1H, dd, J = 10.4 & 5.2 Hz, H6), 2.99 (1H, dddd, J = 10.4, 7.2, 7.2 & 3.2 Hz, 
H1), 2.28–2.22 (3H, m, H2 & H5), 1.97 (2H, dd, J = 11.6 & 6.4, H1'), 1.75 (3H, s, CH3), 1.57 (3H, 
s, CH3), 1.27 (3H, s, CH3); 13C-NMR (100 MHz, CDCl3) δ 204.1, 141.1, 137.9, 131.42, 128.8, 
128.2, 126.4, 122.9, 119.2, 46.5, 44.0, 43.5, 27.3, 25.7, 24.5, 22.7, 17.5; IR (thin film) νmax = 2964 
(m), 2913 (m), 1724 (s), 1602 (w), 1495 (m), 1452 (m), 1377 (m), 750 (m); LRMS (EI+) m/z = 268 
(M+•, 80%), 91 (100%); HRMS (EI+) calcd for C19H24O (M+•) 268.1827, found 268.1824. 
 
To a solution of (3-methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl)methanol 10 
(171 mg, 633 µmol) in dichloromethane (20 mL) was added Dess–Martin periodinane (403 mg, 950 
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µmol) and the mixture was stirred at room temperature for 1 h. The reaction was then evaporated on 
to silica under reduced pressure and purified by column chromatography using diethyl ether : 
hexane (1:9) to afford 3-methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl)methanal 
12 as a clear colorless oil (132 mg, 78%). 
 
General procedure for high pressure reactions (Table 1) 
 
Dienophile (917 mg, 6.94 mmol), E-ocimene 8 (3.79 g, 27.8 mmol) and dichloromethane (3 mL) 
were added to a pressure vessel, sealed and pressurized to 19 kbar for 3 days. The reactions were 
then diluted with dichloromethane (20 mL), evaporated onto silica and purified by column 
chromatography to afford the corresponding Diels–Alder adducts. 
 
Reduction to alcohols. To a solution of Diels–Alder adducts (251 mg, 0.841 mmol) in 
tetrahydrofuran (20 mL) was added lithium aluminum hydride in tetrahydrofuran (3.37 mL, 1 M, 
3.37 mmol) dropwise over 5 min. After 1 h of stirring at room temperature the reaction was cooled 
to 0°C and ethyl acetate (10 mL) was added dropwise over 10 minutes. The reaction was then 
diluted with diethyl ether (80 mL) and a saturated solution of potassium sodium tartrate (80 mL) 
and stirred vigorously for 30 min. The diethyl ether layer was then separated and the aqueous layer 
re-extracted with diethyl ether (2 × 50 mL). The combined organic layers were washed with brine 
(50 mL) and evaporated on to silica with purification by column chromatography to afford the 
corresponding alcohols. 
 
Reduction to aldehydes. To a solution of Diels–Alder adducts (454 mg, 1.71 mmol) in 
dichloromethane (20 mL) was added diisobutylaluminum hydride in dichloromethane (5.13 mL, 1 
M, 5.13 mmol) at −78°C. After 30 min, the reaction was quenched with saturated aqueous sodium 
potassium tartrate (50 mL), and stirred vigorously for 30 min. The dichloromethane layer was then 
separated and the aqueous layer re-extracted with dichloromethane (2 × 50 mL). The combined 
organic layers were washed with brine (50 mL) and evaporated on to silica with purification by 
column chromatography to afford the corresponding aldehydes. 
 
2-Bromo-5-methoxybenzene-1,3-diol (23)[4] 
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To a solution of 5-methoxyresorcinol (1.92 g, 13.7 mmol) in chloroform (100 mL) and dioxane (5 
mL) at 0°C was added portion-wise over 1 h a solution of 2,4,4,6-tetrabromo-2,5-cyclohexadienone 
(6.79 g, 16.6 mmol) in chloroform (20 mL). The resulting reaction mixture was stirred at 0°C for 
5 h and then concentrated under reduced pressure. Purification via silica gel chromatography using 
dichloromethane followed by recrystallization from dichloromethane gave 2-bromo-5-
methoxybenzene-1,3-diol 23 as white crystals (1.60 g, 54%); Rf (DCM) 0.13; m.p. 73–75°C (lit.[5] 
m.p. 73–75°C); 1H-NMR (400 MHz, CDCl3) δ 6.22 (2H, s, CH), 5.41 (2H, s, OH), 3.75 (3H, s, 
CH3O); 13C-NMR (100 MHz, CDCl3) δ 160.7, 153.3, 94.7, 90.6, 55.5; IR (thin film) νmax = 3453 
(m), 2940 (w), 2849 (w), 1597 (vs), 1506 (m), 1444 (m), 1368 (m), 1323 (w) cm–1; LRMS (ESI–) 
m/z = 217 (C7H6O379Br, [M–H]–, 22%), 219 (C7H6O381Br, [M–H]–, 21%), 122 (100%); HRMS 
(ESI–) calcd for C7H6O379Br ([M–H]–) 216.9500, found 216.9500, calcd for C7H6O381Br ([M–H]–) 
218.9480, found 218.9482. 
 
2-Bromo-5-methoxy-1,3-bis(methoxymethoxy)benzene (13)[6]  
 
Sodium hydride 60% dispersion in mineral oil (557 mg, 13.9 mmol) and hexanes (60 mL) were 
added to a flask and stirred vigorously at room temperature for 30 min. The mixture was then 
allowed to settle and the majority of the hexane removed by pipette. Dimethylformamide (30 mL) 
was added to the flask followed by cooling to 0°C. 2-Bromo-5-methoxybenzene-1,3-diol 23 (1.02 g, 
4.66 mmol) was then added portion wise over 20 min followed by methoxymethyl chloride (881 µL, 
11.6 mmol) dropwise over 10 min. After warming to room temperature the resulting solution was 
stirred for 16 h and then diluted with water (60 mL). Extraction with ether (3 × 50 mL), drying over 
magnesium sulfate, concentration under reduced pressure and purification by silica gel 
chromatography using diethyl ether : hexane (1:4) gave 2-bromo-5-methoxy-1,3-
bis(methoxymethoxy)benzene 13 as a clear colorless oil (946 mg, 66%); Rf (diethyl ether:hexane 
3:7) 0.26; 1H-NMR (400 MHz, CDCl3) δ 6.46 (2H, s, CH), 5.22 (4H, s, CH3OCH2O), 3.77 (3H, s, 
CH3O), 3.51 (6H, s, CH3OCH2O); 13C-NMR (100 MHz, CDCl3) δ 160.0, 155.1, 96.2, 95.0, 94.6, 
56.2, 55.4; IR (thin film) νmax = 2963 (s), 2911 (s), 2831 (m), 1605 (s), 1537 (w), 1482 (s), 1391 
(m), 1303 (m) cm–1; LRMS (EI+) m/z = 306 (C11H15O579Br, M+•, 100%), 308 (C11H15O581Br, M+•, 
98%); HRMS (EI+) calcd for C11H15O579Br (M+•) 306.0103, found 306.0103, calcd for 
C11H15O581Br (M+•) 308.0082, found 308.0066. 
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1,3,5-Tris(methoxymethoxy)benzene (24)[7] 
 
Sodium hydride 60% dispersion in mineral oil ( 5.70 g, 143 mmol) and hexane (40 mL) were added 
to a flask and stirred vigorously at room temperature for 30 min. The mixture was then allowed to 
settle and the majority of the hexane removed by pipette. Dimethylformamide (80 mL) was added 
to the flask followed by cooling to 0°C. Phloroglucinol (4.50 g, 35.7 mmol) was then added portion 
wise over 10 min followed by methoxymethyl chloride (8.97 mL, 118 mmol) dropwise over 10 min. 
After warming to room temperature the resulting solution was stirred for 16 h and then diluted with 
water (100 mL). Extraction with ether (3 × 50 mL), drying over magnesium sulfate, concentration 
under reduced pressure and purification by silica gel chromatography using ethyl acetate : hexane 
(1:4) afforded 1,3,5-tris(methoxymethoxy)benzene 24 as a clear colorless oil (5.68 g, 62%); Rf 
(ethyl acetate:hexane 1:4) 0.22; 1H-NMR (400 MHz, CDCl3) δ 6.41 (3H, s, CH), 5.13 (6H, s, 
CH3OCH2O), 3.47 (9H, s, CH3OCH2O); 13C-NMR (100 MHz, CDCl3) δ 158.9, 98.4, 94.5, 56.1; IR 
(thin film) νmax = 2955 (w), 2901 (m), 2827 (m), 1598 (s), 1471 (m), 1439 (w), 1399 (m), 1314 (w) 
cm–1; LRMS (EI+) m/z = 258 (M+•, 55%), 45 (CH3OCH2+, 100%); HRMS (EI+) calcd for C12H18O6 
(M+•) 258.1103, found 258.1116. 
 
2-Bromo-1,3,5-tris(methoxymethoxy)benzene (15)[7]  
 
To a solution of 1,3,5-tris(methoxymethoxy)benzene 24 (5.68 g, 22.0 mmol) in dichloromethane 
(60 mL) was added N-bromosuccinimide (4.11 g, 23.1 mmol) followed by stirring at room 
temperature for 1 h. The reaction was then evaporated on to silica under reduced pressure and 
purified by silica gel chromatography using ethyl acetate : hexane (3:17) to give 2-bromo-1,3,5-
tris(methoxymethoxy)benzene 15 as a white solid (7.34 g, 98%); Rf (ethyl acetate:hexane 1:4) 0.20; 
m.p. 35–40°C; 1H-NMR (400 MHz, CDCl3) δ 6.60 (2H, s, CH), 5.23 (4H, s, CH3OCH2O), 5.14 
(2H, s, CH3OCH2O), 3.52 (6H, s, CH3OCH2O), 3.47 (3H, s, CH3OCH2O); 13C-NMR (100 MHz, 
CDCl3) δ 157.7, 155.2, 98.5, 96.1, 95.1, 94.6, 56.4, 56.1; IR (thin film) νmax = 2957 (m), 2907 (m), 
2828 (m), 1588 (vs), 1469 (m), 1392 (s), 1307 (w), 1232 (m) cm–1; LRMS (EI+) m/z = 336 
(C12H17O679Br, M+•, 100%), 338 (C12H17O681Br, M+•, 100%); HRMS (EI+) calcd for C12H1779BrO6 
(M+•) 336.0208, found 336.0208, calcd for C12H1781BrO6 (M+•) 338.0188, found 338.0192. 
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(±)-((1R,2S,6R)-3-Methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl) (4-methoxy-
2,6-bis(methoxymethoxy) phenyl) methanone (14) 
 
2-Bromo-5-methoxy-1,3-bis(methoxymethoxy)benzene 13 (230 mg, 748 µmol) and tetrahydrofuran 
(15 mL) were added to a flask and cooled to –78°C under a nitrogen atmosphere. Butyl lithium (575 
µL, 1.6 M, 748 µmol) was then added dropwise over 5 min and the resulting solution stirred for 30 
min. A solution of (3-methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl)methanal 12 
(66.9 mg, 249 µmol) in tetrahydrofuran (5 mL) was then added dropwise over 5 min followed by 
stirring at –78°C for 15 min. After this the reaction was allowed to warm to room temperature and 
stirred for a further 30 minutes followed by quenching with a saturated solution of ammonium 
chloride (30 mL). Extraction with diethyl ether (3 × 30 mL), drying over magnesium sulfate and 
purification by column chromatography using diethyl ether : hexane (3:7) gave a mixture of the 
alcohol diastereomer products; Rf (diethyl ether:hexane 1:1) 0.11 & 0.22; The alcohol products, 
Dess–Martin periodinane (211 mg, 498 µmol) and dichloromethane (15 mL) were added to a flask 
and stirred at room temperature for 1 h. The reaction was then evaporated on to silica under reduced 
pressure and purified by column chromatography using diethyl ether : hexane (3:7) to afford (3-
methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl) (4-methoxy-2,6-bis(methoxy-
methoxy)phenyl)methanone 14 as colorless oil (87.5 mg, 71% over 2 steps); Rf (diethyl 
ether:hexane 1:1) 0.19; 1H-NMR (400 MHz, CDCl3) δ 7.31 (2H, d, J = 8.0 Hz, H2'''), 7.23 (2H, t, J 
= 8.0 Hz, H3'''), 7.10 (1H, t, J = 7.2 Hz, H4'''), 6.36 (2H, s, H3), 5.40 (1H, br s, H4'), 5.11 (1H, m, 
H2''), 5.01 (4H, s, CH2OCH3), 3.84 (1H, dd, J = 10.8 & 3.2 Hz, H1'), 3.77 (3H, s, OCH3), 3.48 (1H, 
m, H6'), 3.38 (6H, s, CH2OCH3), 2.51 (1H, m, H5'β), 2.36–2.34 (3H, m, H2' & H1''), 2.17 (1H, m, 
5'α), 1.72 (3H, s, CH3), 1.67 (3H, s, CH3), 1.61 (3H, s, CH3); 13C-NMR (100 MHz, CDCl3) δ 203.3, 
161.8, 156.5, 146.8, 138.3, 130.9, 128.2, 127.7, 125.5, 124.6, 120.6, 114.8, 94.9, 94.5, 58.2, 56.1, 
55.4, 40.7, 36.8, 34.5, 29.6, 25.8, 23.6, 18.0; IR (thin film) νmax = 2960 (m), 2912 (m), 1695 (m), 
1605 (vs), 1452 (m), 1391 (w), 1215 (m), 1151 (vs); LRMS (EI+) m/z = 494 (M+•, 2%), 197 (100%); 
HRMS (EI+) calcd for C30H38O6 (M+•) 494.2668, found 494.2669. 
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(±)-Panduratin A (1[)8]  
 
(3-Methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl) (4-methoxy-2,6-bis(methoxy-
methoxy)phenyl)methanone 14 (83.4 mg, 169 µmol), methanol (10 mL) and 2 drops of 
concentrated hydrochloric acid were added to a flask and heated at 50°C with stirring for 2 h. The 
reaction mixture was then neutralized with saturated sodium bicarbonate solution, extracted with 
ethyl acetate (2 × 30 mL) and dried over magnesium sulfate. Filtration, concentration under reduced 
pressure and purification via silica gel chromatography using diethyl ether : hexane (3:7) afforded 
(±)-panduratin A 1 as a yellow solid (48.3 mg, 70%); Rf (diethyl ether:hexane 1:1) 0.35; m.p. 154–
156°C (lit.[8] m.p. 157–157.5°C); 1H-NMR (400 MHz, CD3OD) δ 7.18–7.16 (4H, m, H2''' & H3'''), 
7.05 (1H, m, H4'''), 5.88 (2H, s, H3), 5.41 (1H br s, H4'), 4.88 (1H, obscured by HOD, H2''), 4.77 
(1H, dd, J = 11.6 & 4.4, H1'), 3.74 (3H, s, OMe), 3.38 (1H, ddd, J = 10.8, 10.8, 6.4 Hz, H6'), 2.65 
(1H, m, H2'), 2.36–2.24 (2H, m, H5'a & H1''a), 2.08–1.95 (2H, m, H5'b & H1''b), 1.77 (3H, s, CH3), 
1.50 (6H, s, CH3); 13C-NMR (100 MHz, CD3OD) δ 208.1, 167.0, 165.4, 148.5, 138.4, 132.4, 129.2, 
128.3, 126.4, 125.7, 122.0, 107.2, 94.4, 55.76, 55.0, 43.4, 38.4, 37.1, 29.8, 25.9, 23.0, 18.1; IR (thin 
film) νmax = 3401 (s), 2964 (w), 2914 (w), 1627 (s), 1581 (m), 1424 (w), 1231 (m), 1162 (m) cm–1; 
LRMS (ESI–) m/z = 405 ([M–H]–, 100%); HRMS (ESI–) calcd for C26H29O4 ([M–H]–) 405.2066, 
found 405.2066. 
 
(±)-((1R,2S,6R)-3-Methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl) (2,4,6-tris-
(methoxymethoxy)phenyl)methanone (16) 
 
2-Bromo-1,3,5-tris(methoxymethoxy)benzene 15 (277 mg, 822 µmol) and tetrahydrofuran (15 mL) 
were added to a flask and cooled to –78°C under a nitrogen atmosphere. Butyl lithium (514 µL, 
1.6M, 823 µmol) was then added dropwise over 5 min and the resulting solution stirred for 30 min. 
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A solution of (3-methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl)methanal 12 (55.2 
mg, 206 µmol) in tetrahydrofuran (5 mL) was then added dropwise over 5 min followed by stirring 
at –78°C for 15 min. After this the reaction was allowed to warm to room temperature and stirred 
for a further 30 min followed by quenching with a saturated solution of ammonium chloride (30 
mL). Extraction with diethyl ether (3 × 30 mL), drying over magnesium sulfate and purification by 
column chromatography using diethyl ether : hexane (3:7) )gave a mixture of the alcohol 
diastereomer products; Rf (diethyl ether:hexane 1:1) 0.20 & 0.28; The alcohol products, Dess–
Martin periodinane (131 mg, 309 µmol) and dichloromethane (15 mL) were added to a flask and 
stirred at room temperature for 1 h. The reaction was then evaporated on to silica under reduced 
pressure and purified by column chromatography using diethyl ether : hexane (3:7) to afford (3-
methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl) (2,4,6-tris(methoxymethoxy)phenyl) 
methanone 16 as colorless oil (78.9 mg, 73% over 2 steps); Rf (diethyl ether:hexane 1:1) 0.37; 1H-
NMR (400 MHz, CDCl3) δ 7.31 (2H, d, J = 7.6 Hz, H2'''), 7.23 (2H, t, J = 7.2 Hz, H3'''), 7.11 (1H, t, 
J = 7.2 Hz, H4'''), 6.48 (2H, s, H3), 5.41 (1H, br s, H4'), 5.13 (3H, s, H2'' & CH2OCH3), 5.00 (4H, s, 
CH2OCH3), 3.81 (1H, dd, J = 11.2 & 3.2 Hz, H1'), 3.52–3.47 (4H, m, H6' & CH2OCH3), 3.37 (6H, 
s, CH2OCH3), 2.51 (1H, m, H5'β), 2.36–2.33 (3H, m, H2' & H1''), 2.17 (1H, m, H5'α), 1.73 (3H, s, 
CH3), 1.67 (3H, s, CH3), 1.61 (3H, s, CH3); 13C-NMR (100 MHz, CDCl3) δ 203.3, 159.4, 156.3, 
146.7, 138.3, 130.9, 128.3, 127.7, 125.5, 124.6, 120.7, 115.9, 97.0, 94.5, 94.4, 58.3, 56.3, 56.2, 40.6, 
36.7, 34.4, 29.6, 25.8, 23.6, 18.0; IR (thin film) νmax = 2959 (m), 2911 (m), 1697 (m), 1605 (s), 
1451 (w), 1217 (w), 1155 (s), 1050 (vs); LRMS (EI+) m/z = 524 (M+•, 3%), 389 (100%); HRMS 
(EI+) calcd for C31H40O7 (M+•) 524.2774, found 524.2794. 
 
(±)-4-Hydroxypanduratin A (2)[9]  
 
(3-Methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1yl) (2,4,6-tris(methoxymethoxy)-
phenyl) methanone 16 (69.7 mg, 141 µmol), methanol (10 mL) and 2 drops of concentrated 
hydrochloric acid were added to a flask and heated at 50°C with stirring for 2 h. The reaction 
mixture was then neutralized with saturated sodium bicarbonate solution, extracted with ethyl 
acetate (2 × 30 mL) and dried over magnesium sulfate. Filtration, concentration under reduced 
pressure and purification via silica gel chromatography using diethyl ether : hexane (2:3) afforded 
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(±)-4-hydroxypanduratin A 2 as a pale yellow oil (39.3 mg, 71%); Rf (diethyl ether:hexane 1:1) 
0.17; 1H-NMR (400 MHz, CD3OD) δ 7.18–7.17 (4H, m, H2''' & H3'''), 7.05 (1H, m, H4'''), 5.78 
(2H, s, H3), 5.40 (1H, br s, H4'), 4.91 (1H, obscured by HOD, H2''), 4.76 (1H, dd, J = 12.0, 4.8 Hz, 
H1'), 3.37 (1H, ddd, J = 10.4, 10.4, 6.4, H6'), 2.65 (1H, m, H2'), 2.36–2.22 (2H, m, H5'a & H1''a), 
2.08–1.94 (2H, m, H5'b & H1''b), 1.77 (3H, s, CH3), 1.51 (6H, s, CH3); 13C-NMR (100 MHz, 
CD3OD) δ 207.8, 165.5, 148.6, 138.4, 132.2, 129.1, 128.2, 126.4, 125.7, 121.9, 106.5, 95.8 (2 × C), 
54.8, 43.8, 38.4, 37.1, 29.9, 25.9, 23.0, 18.0; IR (thin film) νmax = 3400 (vs), 2958 (w), 2913 (w), 
1623 (s), 1597 (m), 1492 (w), 1436 (w), 1216 (w) cm–1; LRMS (ESI–) m/z = 391 ([M–H]–, 100%); 
HRMS (ESI–) calcd for C25H27O4 ([M–H]–) 391.1909, found 391.1909. 
 
(±)-((1R,5S,6R)-4-Methyl-5-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl) (4-methoxy-
2,6-bis(methoxymethoxy)phenyl) methanone (20) 
 
2-Bromo-5-methoxy-1,3-bis(methoxymethoxy)benzene 13 (229.7 mg, 748 µmol) and 
tetrahydrofuran (20 mL) were added to a flask and cooled to –78°C under a nitrogen atmosphere. 
Butyl lithium (575 µL, 1.3 M, 748 µmol) was then added dropwise over 5 min and the resulting 
solution stirred for 30 min. A solution of (3-methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-
en-1-yl)methanal 19 (66.9 mg, 249 µmol) in tetrahydrofuran (5 mL) was then added dropwise over 
5 min followed by stirring at –78°C for 15 min. After this the reaction was allowed to warm to 
room temperature and stirred for a further 30 min followed by quenching with a saturated solution 
of ammonium chloride (30 mL). Extraction with diethyl ether (3 × 20 mL), drying over magnesium 
sulfate and purification by column chromatography using diethyl ether : hexane (1:3) gave a 
mixture of the alcohol diastereomer products; Rf (diethyl ether:hexane 1:1) 0.11 & 0.19; The 
alcohol products, Dess–Martin periodinane (158 mg, 374 µmol) and dichloromethane (10 mL) were 
added to a flask and stirred at room temperature for 1 h. The reaction was then evaporated on to 
silica under reduced pressure and purified by column chromatography using diethyl ether : hexane 
(3:7) to afford (3-methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl) (4-methoxy-2,6-
bis(methoxymethoxy)phenyl) methanone 20 as colorless oil (85.0 mg, 69% over 2 steps); Rf 
(diethyl ether:hexane 1:1) 0.39; 1H-NMR (400 MHz, CDCl3) δ 7.23–7.08 (5H, m, H2''', H3''', H4'''), 
6.37 (2H, s, H3), 5.48 (1H, s, H3'), 5.06–4.98 (4H, m, CH2OCH3), 4.87 (1H, t, J = 6.4 Hz, H2''), 
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3.79 (3H, s, OMe), 3.71 (1H, dd, J = 16.0 & 7.2 Hz, H6'), 3.47–3.42 (7H, m, H1' & CH2OCH3), 
2.35–2.32 (3H, m, H2' & H5'), 2.04–1.90 (2H, m, H1''), 1.74 (3H, s, CH3), 1.55 (3H, s, CH3), 1.25 
(3H, s, CH3); 13C-NMR (100 MHz, CDCl3) δ 204.8, 162.0, 156.2, 143.2, 137.2, 130.9, 129.0, 127.6, 
125.6, 123.6, 120.6, 115.1, 94.8, 94.7, 56.2, 55.4, 48.4, 45.5, 43.5, 27.8, 27.0, 25.7, 22.7, 17.5; IR 
(thin film) νmax = 2960 (w), 2913 (w), 1698 (m), 1606 (s), 1452 (w), 1153 (s), 1048 (s), 924 (w) 
cm−1; LRMS (EI+) m/z = 494 (M+•, 2%), 255 (100%); HRMS (EI+) calcd for C30H38O6 (M+•) 
494.2668, found 494.2673. 
 
(±)-Nicolaioidesin B (5)[10]  
 
(3-Methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl) (4-methoxy-2,6-bis(methoxy-
methoxy)phenyl) methanone 20 (71.3 mg, 175 µmol), methanol (10 mL) and 4 drops of 
concentrated hydrochloric acid were added to a flask and heated at 50°C with stirring for 2 h. The 
reaction mixture was then neutralized with saturated sodium bicarbonate solution, extracted with 
ethyl acetate (2 × 20 mL) and dried over magnesium sulfate. Filtration, concentration under reduced 
pressure and purification via silica gel chromatography using diethyl ether : hexane (35:65) 
afforded (±)-nicolaioidesin B 5 as a pale yellow oil (49.1 mg, 69%); Rf (diethyl ether:hexane 2:3) 
0.07; 1H-NMR (400 MHz, CD3OD) δ 7.18–7.11 (4H, m, H2''' & H3'''), 7.07 (1H, m, H4'''), 5.93 
(2H, s, H3), 5.49 (1H, s, H4'), 4.92 (1H, m, H6'), 4.88 (1H, m, H2''), 3.77 (3H, s, OMe), 3.51 (1H, 
dd, J = 11.6 & 5.2 Hz, H1'), 2.61 (1H, m, H5'a), 2.24 (1H, m, H2'), 2.07–1.83 (3H, m, H5'b & H1''), 
1.75 (3H, s, CH3), 1.57 (3H, s, CH3), 1.34 (3H, s, CH3); 13C-NMR (100 MHz, CD3OD) δ 211.2, 
167.4, 165.5, 144.9, 138.6, 131.4, 129.4, 129.0, 126.7, 124.8, 121.4, 106.8, 94.5, 55.8, 47.6, 47.0, 
44.6, 31.9, 29.0, 26.1, 23.3, 18.0; IR (thin film) νmax = 3292 (w), 2964 (w), 2913 (w), 1625 (vs), 
1575 (s), 1377 (w), 1211 (s), 1079 (w) cm–1; LRMS (ESI–) m/z = 405 ([M–H]–, 40%), 113 (100%); 
HRMS (ESI–) calcd for C26H29O4 ([M–H]–) 405.2066, found 405.2067. 
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(±)-((1R,5S,6R)-4-Methyl-5-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl) (2,4,6-
tris(methoxymethoxy)phenyl) methanone (21) 
 
2-Bromo-1,3,5-tris(methoxymethoxy)benzene 15 (136 mg, 406 µmol) and tetrahydrofuran (10 mL) 
were added to a flask and cooled to –78°C under a nitrogen atmosphere. Butyl lithium (162 µL, 1.6 
M, 406 µmol) was then added dropwise over 5 min and the resulting solution stirred for 30 min. A 
solution of (4-methyl-5-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-ene-1-yl)methanal 19 (36.3 
mg, 135 µmol) in tetrahydrofuran (5 mL) was then added dropwise over 5 min followed by stirring 
at –78°C for 15 min. After this the reaction was allowed to warm to room temperature and stirred 
for a further 30 min followed by quenching with a saturated solution of ammonium chloride (30 
mL). Extraction with diethyl ether (3 × 20 mL), drying over magnesium sulfate and purification by 
column chromatography using diethyl ether : hexane (1:3) )gave a mixture of the alcohol 
diastereomer products; Rf (diethyl ether:hexane 1:1) 0.11 & 0.19; The alcohol products, Dess–
Martin periodinane (83.2 mg, 196 µmol) and dichloromethane (5 mL) were added to a flask and 
stirred at room temperature for 1 h. The reaction was then evaporated on to silica under reduced 
pressure and purified by column chromatography using diethyl ether : hexane (3:7) to afford (4-
methyl-5-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-en-1-yl) (2,4,6-tris(methoxymethoxy)phenyl) 
methanone 21 as colorless oil (50.3 mg, 71% over 2 steps); Rf (diethyl ether:hexane 2:3) 0.17; 1H-
NMR (400 MHz, CDCl3) δ 7.24–7.16 (4H, m, H2''' & H3'''), 7.11 (1H, m, H4'''), 6.50 (2H, s, H3), 
5.47 (1H, s, H3'), 5.15 (2H, s, CH2OCH3), 5.07–4.99 (4H, m, CH2OCH3), 4.87 (1H, m, H2''), 3.69 
(1H, dd, J = 8.4 & 7.2 Hz, H6'), 3.50–3.42 (10H, m, H1'& CH2OCH3), 2.35–2.34 (3H, m, H2' & 
H5'), 2.04–1.90 (2H, m, H1''), 1.75 (3H, s, CH3), 1.55 (3H, s, CH3), 1.24 (3H, s, CH3); 13C-NMR 
(100 MHz, CDCl3) δ 204.7, 159.6, 155.9, 143.2, 137.3, 131.0, 129.0, 127.6, 125.6, 123.6, 120.5, 
116.0, 96.8, 94.7, 94.4, 56.3 (2 × C), 48.5, 45.3, 43.4, 27.8, 26.8, 25.7, 22.7, 17.5; IR (thin film) 
νmax = 2959 (m), 2912 (m), 1700 (m), 1605 (s), 1451 (m), 1216 (m), 1155 (s), 1050 (s) cm–1; 
LRMS (EI+) m/z = 524 (M+•, 1%), 285 (100%); HRMS (EI+) calcd for C31H40O7 (M+•) 524.2774, 
found 524.2790. 
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(±)-4-Hydroxyisopanduratin A (6)[11]  
 
(3-Methyl-2-(3-methylbut-2-enyl)-6-phenylcyclohex-3-enyl)(2,4,6-tris(methoxymethoxy)phenyl)-
methanone 21 (40.0 mg, 76.2 µmol), methanol (10 mL) and 4 drops of concentrated hydrochloric 
acid were added to a flask and heated at 50°C with stirring for 2 h. The reaction mixture was then 
neutralized with saturated sodium bicarbonate solution, extracted with ethyl acetate (2 × 20 mL) 
and dried over magnesium sulfate. Filtration, concentration under reduced pressure and purification 
via silica gel chromatography using diethyl ether : hexane (35:65) afforded (±)-4-
hydroxyisopanduratin A 6 as a pale yellow oil (21.1 mg, 71%); Rf (diethyl ether:hexane 2:3) 0.07; 
1H-NMR (800 MHz, CD3OD) δ 7.19–7.06 (5H, m, H2''', H3''' & H4'''), 5.81 (2H, s, H3), 5.49 (1H, s, 
H4'), 4.92 (1H, ddd, J = 11.1, 11.1 & 6.1 Hz, H6'), 4.88 (1H, obscured by HOD, H2''), 3.50 (1H, dd, 
J = 11.7 & 5.0 Hz, H1'), 2.60 (1H, m, H5'β), 2.24 (1H, m, H2'), 2.05–1.96 (2H, m, H1''), 1.86 (1H, 
m, 5'α), 1.75 (3H, s, CH3), 1.57 (3H, s, CH3), 1.34 (3H, s, CH3); 13C-NMR (200 MHz, CD3OD) δ 
210.8, 166.1, 145.0, 138.6, 131.4, 129.5, 129.0, 126.7, 124.9, 121.5, 106.1, 95.9 (2 × C), 47.6, 47.1, 
44.4, 31.9, 29.1, 26.1, 23.3, 17.9; IR (thin film) νmax = 3235 (w), 2918 (w), 2853 (w), 1627 (s), 
1599 (s), 1451 (m), 1202 (m), 1073 (m) cm–1; LRMS (ESI–) m/z = 392 ([M–H]–, 10%), 153 (100%); 
HRMS (ESI–) calcd for C25H27O4 ([M–H]–) 391.1909, found 391.1899.  
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Panduratin H (3) 1H NMR Comparison. 
 
 
 
Proton δL (Lit.,[3] 400 MHz, CDCl3) δ3 (Compound 3, 400 MHz, CDCl3) Δδ (δL–δ3) 
H3'' 7.25 (m) 7.26 (m) –0.01 
H2'', H4'' 7.15 (m) 7.17a (m) 0.02 
H4 5.42 (s) 5.42 (s) 0.00 
H2' 5.06 (t, 6.8) 5.06 (m) 0.00 
OCH3 3.40 (s) 3.40 (s)  0.00 
H6 3.19 (ddd, 11.2, 10.0, 6.0) 3.19 (ddd, 12.0, 10.4, 6.4) 0.00 
H1 3.09 (dd, 11.2, 5.4) 3.08 (dd, 12.4, 4.8) 0.01 
H2 2.45 (dd, 10.2, 5.4) 2.45 (dd, 10.4, 5.2) 0.00 
H5β 2.34 (dt, 18.3, 6.0, 1.9) 2.32
a (m) – 
H1'a 2.26 (m) – 
H1'b 2.18 (m) 2.17 (m) 0.01 
H5α 2.04 (m) 2.04 (m) 0.00 
CH3 1.77 (s) 1.78 (s) –0.01 
CH3 1.67 (s) 1.67 (s) 0.00 
CH3 1.59 (s) 1.60 (s) –0.01 
aCalculated from midpoint of multiplet. 
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Panduratin H (3) 13C NMR Comparison. 
 
 
 
Carbon δL (Lit.,[3] 100 MHz, CDCl3) δ3 (Compound 3, 100 MHz, CDCl3) Δδ (δL–δ3) 
COOCH3 173.7 173.8 –0.1 
C1'' 145.9 145.9 0.0 
C3 136.3 136.3 0.0 
C3' 131.9 132.0 –0.1 
C3'', C5'' 128.3 128.3 0.0 
C2'', C6'' 127.1 127.1 0.0 
C4'' 125.9 126.0 –0.1 
C2' 123.0 123.8 –0.8 
C4 121.1 121.0 0.1 
COOCH3 51.0 51.0 0.0 
C1 49.2 49.1 0.1 
C2 42.7 42.6 0.1 
C6 37.2 37.1 0.1 
C5 35.1 35.1 0.0 
C1' 29.2 29.2 0.0 
C4' 25.9 25.9 0.0 
3-CH3 22.6 22.6 0.0 
C5' 17.9 17.9 0.0 
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Panduratin I (4) 1H NMR Comparison. 
 
 
 
Proton δL (Lit.,[3] 400 MHz, CDCl3) δ3 (Compound 4, 400 MHz, CDCl3) Δδ (δL–δ4) 
H3'' 7.25 (m) 7.26 (m) –0.01 
H2'', H4'' 7.15 (m) 7.17a (m) –0.02 
H4 5.45 (s) 5.45 (s) 0.00 
H2' 4.80 (t, 7.6) 4.81 (m) –0.01 
OCH3 3.49 (s) 3.49 (s) 0.00 
H1 3.33 (dd, 11.2, 5.6) 3.33 (dd, 11.2, 5.2) 0.00 
H6 3.18 (ddd, 11.2, 9.6, 6.1) 3.18 (ddd, 11.2, 9.6, 6.4) 0.00 
H5β 2.43 (dt, 18.0, 6.1, 1.9) 2.44 (m) –0.01 
H5α 2.34 (m) 2.32, (m) 0.02 
H2 2.21 (dd, 10.2, 5.6) 2.23 (dd, 10.8, 5.2) –0.02 
H1' 1.93 (m) 1.93a (m) 0.00 
CH3 1.74 (s) 1.74 (s) 0.00 
CH3 1.56 (s) 1.57 (s) –0.01 
CH3 1.34 (s) 1.34 (s) 0.00 
aCalculated from midpoint of multiplet. 
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Panduratin I (4) 13C NMR Comparison. 
 
 
 
Carbon δL (Lit.,[3] 100 MHz CDCl3) δ3 (Compound 3, 100 MHz, CDCl3) Δδ (δL–δ4) 
COOCH3 176.5 176.5 0.0 
C1'' 142.4 142.3 0.1 
C3 137.7 137.6 0.1 
C3' 131.0 131.0 0.0 
C2'', C4'', C6'' 128.2 128.2 – 
128.1 – 
C3'', C5'' 126.2 126.1 0.1 
C2' 123.4 123.4 0.0 
C4 119.5 119.5 0.0 
COOCH3 51.5 51.5 0.0 
C1 46.3 46.3 0.0 
C2 44.6 44.5 0.1 
C6 39.9 39.9 0.0 
C5 29.5 29.5 0.0 
C1' 27.7 27.6 0.1 
C4' 25.8 25.8 0.0 
3-CH3 22.9 22.9 0.0 
C5' 17.7 17.7 0.0 
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Panduratin A (1) 1H NMR Comparison. 
 
 
 
Proton δL (Lit.,[8] 500 MHz, CDCl3) δ3 (Compound 1, 400 MHz, CD3OD) Δδ (δL–δ1) 
H2'', H3'' 7.21 (m) 7.17a (m) 0.04 
H4'' 7.10 (m) 7.05 (m) 0.05 
H3 5.87 (s) 5.88 (s) –0.01 
H4' 5.43 (s) 5.41 (s) 0.02 
H2'' 4.87 (t, 6.7) 4.88b –0.01 
H1' 4.66 (dd, 11.3, 4.6) 4.77 (dd, 11.6, 4.4) –0.11 
OMe 3.74 (s) 3.74 (s) 0.00 
H6' 3.43 (ddd, 11.0, 11.0, 6.3) 3.38 (ddd, 10.8, 10.8, 6.4) 0.05 
H2' 2.63 (m) 2.65 (m) –0.02 
H5'a, H1''a 2.40 (m) 2.30a (m) 0.10 
H5'b, H1''b 2.03 (m) 2.02a (m) 0.01 
CH3 1.78 (s) 1.77 (s) 0.01 
CH3 1.52 (s) 1.50 (s) 0.02 
aCalculated from midpoint of multiplet.  
bObscured by HOD peak, chemical shift determined from COSY. 
 
  
S22
 
 
Panduratin A (1) 13C NMR Comparison. 
 
 
 
Carbon δL (Lit.,[8] 125 MHz, CDCl3) δ3 (Compound 1, 100 MHz, CD3OD) Δδ (δL–δ1) 
C=O 206.4 208.1 –1.7 
C2 165.0 167.0 –2.0 
C4 165.0 165.4 –0.4 
C1''' 147.0 148.5 –1.5 
C3' 137.1 138.4 –1.3 
C3'' 131.9 132.4 –0.5 
C3''' 128.3 129.2 –0.9 
C2''' 127.0 128.3 –1.3 
C4''' 125.6 126.4 –0.6 
C2'' 124.2 125.7 –1.5 
C4' 121.1 122.0 –0.9 
C1 105.7 107.2 –1.5 
C3 94.5 94.4 0.1 
OMe 55.4 55.8 –0.4 
C1' 53.9 55.0 –1.1 
C2' 42.6 43.4 –0.6 
C6' 37.0 38.4 –1.4 
C5' 35.9 37.1 –1.2 
C1'' 28.8 29.8 –1.0 
9'-CH3 25.6 25.9 –0.3 
3'-CH3 22.7 23.0 –0.3 
9'-CH3 17.9 18.1 –0.2 
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4-Hydroxypanduratin A (2) 1H NMR Comparison. 
 
 
 
Proton δL (Lit.,[9] 600 MHz, CD3OD) δ3 (Compound 2, 400 MHz, CD3OD) Δδ (δL–δ2) 
H2'', H3'' 7.17 (m) 7.18a (m) –0.01 
H4'' 7.05 (m) 7.05 (m) 0.00 
H3 5.76 (s) 5.78 (s) –0.02 
H4' 5.41 (ddd, 4.5, 2.8, 1.9) 5.40 (s) 0.01 
H2'' 4.90 (dd, 7.1, 7.1) 4.91b –0.01 
H1' 4.75 (dd, 11.6, 4.7) 4.76 (dd, 12.0, 4.8) –0.01 
H6' 3.36 (ddd, 11.6, 10.6, 6.4) 3.37 (ddd, 10.4, 10.4, 6.4) –0.01 
H2' 2.64 (dddd, 7.2, 4.7, 4.5, 1.6) 2.65 (m) –0.01 
H5'a 2.33 (dddq, 18.1, 6.4, 4.5, 1.9) 2.29a (m) – 
H1''a 2.25 (ddd, 15.2, 7.2, 7.1) – 
H1b'' 2.05 (ddd, 15.2, 7.1, 4.5) – 
H5'b 1.98 (ddddq, 10.6, 2.8, 1.9, 1.6) 2.01 (m) –0.03 
CH3 1.77 (ddd, 1.9, 1.9, 1.9) 1.77 (s) 0.00 
CH3 1.51 (s) 1.51 (s) 0.00 
aCalculated from midpoint of multiplet. 
bObscured by HOD peak, chemical shift determined from COSY. 
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4-Hydroxypanduratin A (2) 13C NMR Comparison. 
 
 
 
Carbon δL (Lit.,[9] 150MHz, DMSO-d6) δ3 (Compound 2, 100 MHz, CD3OD) Δδ (δL–δ2) 
C=O 205.7 207.8 –2.1 
C4 164.3 165.5 – 
C2 164.1 – 
C1''' a 148.6 – 
C1'' 137.1b 138.4 –1.3 
C3'' 130.6 132.2 –1.6 
C3''' 128.1 129.1 –1.0 
C2''' 126.9 128.2 –1.3 
C4''' 125.3 126.4 –1.1 
C2'' 124.3 125.7 –1.4 
C4' 120.9 121.9 –1.0 
C1 104.7 106.5 –1.8 
C3 94.8 95.8 –1.0 
C1' 52.8 54.8 –2.0 
C2' 42.1 43.8 –1.7 
C6' 36.4 38.4 –2.0 
C5' 35.7 37.1 –1.4 
C1'' 28.4 29.9 –1.5 
CH3 25.5 25.9 –0.4 
CH3 22.6 23.0 –0.4 
CH3 17.6 18.0 –0.4 
aNot reported in isolation paper 
bReported as 7.1 and assumed to be a typographical error 
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Nicolaioidesin B (5) 1H NMR Comparison. 
 
 
 
Proton δL (Lit.,[10] 500 MHz, CDCl3) δ3 (Compound 5, 400 MHz, CD3OD) Δδ (δL–δ5) 
H 7.16a (m) 7.15a (m) 0.01 
H 7.08 (m) 7.07 (m) 0.01 
H3 5.92 (s) 5.93 (s) –0.01 
H4' 5.49 (s) 5.49 (s) 0.00 
H6' 4.86 (t, 5.9) 4.92 (m) –0.06 
H2'' 4.76 (ddd, 11.0, 11.0, 6.1) 4.88b (m) –0.12 
OMe 3.76 (s) 3.77 (s) –0.01 
H1' 3.57 (dd, 11.0, 5.1) 3.51 (dd, 11.6, 5.2) 0.06 
H5'a 2.62 (dt, 18.0, 4.2) 2.61 (m) 0.01 
H2' 2.27 (dt, 5.0, 4.9) 2.24 (m) 0.03 
H1'', H5'b 1.97 (m) 1.95a (m) 0.02 
3-CH3 1.76 (s) 1.75 (s) 0.01 
3''-CH3 1.56 (s) 1.57 (s) –0.01 
3''-CH3 1.33 (s) 1.34 (s) –0.01 
aCalculated from midpoint of multiplet. 
bObscured by HOD peak, chemical shift determined from COSY. 
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Nicolaioidesin B (5) 13C NMR Comparison. 
 
 
 
Carbon δL (Lit.,[10] 125 MHz, CDCl3) δ3 (Compound 5, 100 MHz, CD3OD) Δδ (δL–δ5) 
C=O 209.2 211.2 –2.0 
4 165.4 167.4 –2.0 
2 162.7 165.5 –2.8 
1''' 143.4 144.9 –1.5 
3' 137.6 138.6 –1.0 
3'' 130.4 131.4 –1.0 
2''' 128.1 129.4 –1.3 
3''' 128.1 129.0 –0.9 
4''' 125.7 126.7 –1.0 
2'' 123.8 124.8 –1.0 
4' 120.1 121.4 –1.3 
1 105.2 106.8 –1.6 
3 94.6 94.5 –0.9 
OMe 55.5 55.8 –0.3 
1' 46.0 47.6 –1.6 
2' 45.6 47.0 –1.4 
6' 43.8 44.6 –0.8 
5' 30.9 31.9 –1.0 
1'' 28.0 29.0 –1.0 
3''-CH3 25.9 26.1 –0.2 
3'-CH3 22.9 23.3 –0.4 
3''-CH3 17.8 18.0 –0.2 
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4-Hydroxyisopanduratin A (6) 1H NMR Comparison. 
 
 
 
Proton δL (Lit.,[11] 400 MHz, CD3OD) δ3 (Compound 6, 800 MHz, CD3OD) Δδ (δL–δ6) 
H2''' 7.16a (m) 7.17a (m) –0.01 
H3''', H4''' 7.06 (m) 7.07 (m) –0.01 
H3 5.80 (s) 5.81 (s) –0.01 
H4' 5.47 (s) 5.49 (s) –0.02 
H2'' 4.80 (t, 7.0) 4.91 (m) –0.11 
H6' 4.77 (ddd, 11.9, 11.9, 6.0) 4.87b –0.10 
H1' 3.49 (dd, 11.9, 5.1) 3.50 (dd, 11.7, 5.0) –0.01 
H5'b 2.61 (ddd, 17.3, 6.0, 1.9) 2.60 (d, 17.3) 0.01 
H2' 2.23 (dd, 9.8, 5.1) 2.24 (m) –0.01 
H5'a 2.04 (ddd, 17.3, 11.9, 1.9) 2.00 (m) 0.04 
H1'' 1.94a (m) 1.86a (m) –0.07 
CH3 1.74 (s) 1.75 (s) –0.01 
CH3 1.57 (s) 1.57 (s) 0.00 
CH3 1.42 (s) 1.34 (s) 0.08 
aCalculated from midpoint of multiplet. 
bObscured by HOD peak, chemical shift determined from COSY. 
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4-Hydroxyisopanduratin A (6) 13C NMR Comparison. 
 
 
 
Carbon δL (Lit.,[11] 100 MHz, CD3OD) δ3 (Compound 6 ppm, 200 MHz, CD3OD) Δδ (δL–δ3) 
C7 210.7 210.8 –0.1 
C2, C4 165.9 166.1 –0.2 
C1''' 144.9 145.0 –0.1 
C3' 138.5 138.6 –0.1 
C3'' 131.3 131.4 –0.1 
C3''' 129.4 129.5 –0.1 
C2''' 128.9 129.0 –0.1 
C4''' 126.6 126.7 –0.1 
C2'' 124.9 124.9 0.0 
C4' 121.4 121.5 –0.1 
C1 106.1 106.1 0.0 
C3 95.9 95.9 0.0 
C1' 47.5 47.6 –0.1 
C2' 47.0 47.1 –0.1 
C6' 44.4 44.4 0.0 
C5' 31.9 31.9 0.0 
C1'' 29.1 29.1 0.0 
C4'' 26.1 26.1 0.0 
3'CH3 23.3 23.3 0.0 
C5'' 17.9 17.9 0.0 
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Computational Details 
 
The geometries of all compounds were optimized at the B3LYP/6-31+G(d) level of theory. 
Systematic conformer searching was carried out to locate the lowest energy conformer of each 
compound, and vibrational frequencies were computed at the same level of theory to confirm that 
these are indeed global minimum energy structures. Geometry optimization and frequency 
calculations were performed using the Gaussian09 program.[12] The atomic coefficients of the p 
orbitals were calculated at the B3LYP/6-31G(d) level of theory and these were carried out using the 
GAMESSPLUS package.[13]  
 
 
Table S1. The B3LYP/6-31G(d) orbital coefficients of the 2pz and 3pz atomic orbitals 
on carbon atoms C2 and C3 in the LUMOa of the dienophile. 
 
X= 
 
C3 C2 
C(O)OMe 2Pz 0.297 –0.259 
 
3Pz 0.333 –0.317 
C(O)OEt 2Pz 0.295 –0.260 
 
3Pz 0.332 –0.318 
C(O)OCH2CF3 2Pz 0.308 –0.249 
 
3Pz 0.342 –0.305 
C(O)OtBu 2Pz 0.293 –0.260 
 
3Pz 0.330 –0.317 
C(O)H 2Pz 0.308 –0.228 
 
3Pz 0.319 –0.268 
CN 2Pz 0.306 –0.288 
 
3Pz 0.341 –0.344 
aThe HOMO(diene)/LUMO(dienophile) pair has the smaller HOMO-LUMO energy gap. 
 
 
B3LYP/6-31+G(d) Optimized Geometries 
(E)-Ocimene 8 
1\1\GINC-X99\FOpt\RB3LYP\Gen\C10H16\JMH502\22-Nov-2011\0\\#B3LYP/gen 
 6D INT(grid=ultrafine) OPT IOP(2/17=4) Freq=noraman 
 maxdisk=458752000\\diene.a1b3.freq\\0,1\C,-0.0405851764,0.0105054699,0 
 .0053161552\C,-0.0442948282,0.1664628127,1.3377679647\H,0.9215610749,- 
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 0.1183696032,-0.4959264884\H,0.8835605129,0.2155148495,1.9017734026\H, 
 -0.9689966901,0.2416491764,1.9055077407\C,-1.2287195827,-0.0503967268, 
 -0.8766232606\C,-2.2967446031,0.7421459353,-0.6488334183\C,-1.10425571 
 88,-1.0309566721,-2.0233016309\C,-3.60857321,0.7953604735,-1.397199929 
 9\H,-2.2330346664,1.437434396,0.1884548776\H,-0.2038744121,-0.81592322 
 2,-2.6154786821\H,-0.9951238907,-2.0577121945,-1.6481110559\H,-1.96019 
 63824,-1.0105401052,-2.7018793014\H,-3.7676063685,1.8162141509,-1.7659 
 833268\H,-3.5774946959,0.1492196623,-2.2828318228\C,-4.761283379,0.363 
 427998,-0.5158688005\C,-5.8030781834,1.0927884071,-0.0786041533\H,-4.7 
 053029023,-0.6777392625,-0.1930509066\C,-6.8581639933,0.4729943067,0.8 
 099671274\C,-6.0440187583,2.5479564662,-0.4045343435\H,-7.0077173851,2 
 .6744489057,-0.9184022331\H,-6.1031850757,3.144183093,0.5172299229\H,- 
 5.2685482369,2.9877962368,-1.0364832721\H,-7.852657732,0.5354209961,0. 
 3449275467\H,-6.6477189415,-0.5807292124,1.0209930472\H,-6.9284141122, 
 1.0053285449,1.7696192395\\Version=EM64L-G03RevE.01\State=1-A\HF=-390. 
 662807\RMSD=4.610e-09\RMSF=3.957e-06\Thermal=0.\Dipole=-0.1884948,0.04 
 73043,-0.1222158\PG=C01 [X(C10H16)]\\@ 
  
17, X = CN  
1\1\GINC-X99\POpt\RB3LYP\Gen\C9H7N1\JMH502\16-Nov-2011\1\\#B3LYP/gen 
 6D INT(grid=ultrafine) OPT=(Z-matrix) IOP(2/17=4) Freq=noraman 
 maxdisk=458752000\\eto-dienophile.freq\\0,1\C\C,1,cc2\C,2,cc3,1,ccc3\C 
 ,3,cc4,2,ccc4,1,dih4,0\C,4,cc5,3,ccc5,2,dih5,0\C,1,cc6,2,ccc6,3,dih6,0 
 \H,2,hc7,1,hcc7,6,dih7,0\H,3,hc8,2,hcc8,1,dih8,0\H,4,hc9,3,hcc9,2,dih9 
 ,0\H,5,hc10,4,hcc10,3,dih10,0\H,6,hc11,1,hcc11,2,dih11,0\C,1,cc12,2,cc 
 c12,3,dih12,0\C,12,cc13,1,ccc13,2,dih13,0\H,12,hc14,1,hcc14,2,dih14,0\ 
 C,13,cc15,12,ccc15,1,dih15,0\H,13,hc16,12,hcc16,1,dih16,0\X,15,1.,13,9 
 0.,12,180.,0\N,15,nc18,17,ncxx18,13,dih18,0\\cc2=1.40972775\cc3=1.3920 
 2365\ccc3=120.69522174\cc4=1.40078177\ccc4=120.34102277\dih4=0.\cc5=1. 
 39668263\ccc5=119.68737746\dih5=0.\cc6=1.40809063\ccc6=118.25289198\di 
 h6=0.\hc7=1.08622795\hcc7=120.19034854\dih7=180.\hc8=1.08678972\hcc8=1 
 19.65619899\dih8=180.\hc9=1.08671384\hcc9=120.09408092\dih9=180.\hc10= 
 1.08668184\hcc10=120.23013944\dih10=180.\hc11=1.08770529\hcc11=119.213 
 57822\dih11=180.\cc12=1.46394125\ccc12=123.38454357\dih12=180.\cc13=1. 
 35207371\ccc13=127.1302215\dih13=0.\hc14=1.08889079\hcc14=115.31291014 
 \dih14=180.\cc15=1.42528951\ccc15=122.12993471\dih15=180.\hc16=1.08690 
 591\hcc16=122.2071591\dih16=0.\nc18=1.16567148\ncxx18=88.83624971\dih1 
 8=180.\\Version=EM64L-G09RevA.02\State=1-A'\HF=-401.9108452\RMSD=9.086 
 e-09\RMSF=2.509e-05\Dipole=1.9149371,0.,1.0754856\Quadrupole=-6.466058 
 6,1.1711651,5.2948935,0.,-9.1619617,0.\PG=CS [SG(C9H7N1)]\\@ 
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17, X = CHO  
1\1\GINC-X148\FOpt\RB3LYP\Gen\C9H8O1\JMH502\15-Nov-2011\0\\#B3LYP/gen 
 6D INT(grid=ultrafine) OPT IOP(2/17=4) Freq=noraman 
 maxdisk=458752000\\formyl-dienophile.freq\\0,1\C,-0.0167218863,0.,0.11 
 30606826\C,0.0938643813,0.,1.5187258546\C,1.3431657735,0.,2.1329476005 
 \C,2.511401109,0.,1.3600981269\C,2.4197895056,0.,-0.0339656025\C,1.167 
 7659125,0.,-0.6490286164\H,-0.8014935685,0.,2.1333144299\H,1.409319515 
 7,0.,3.217746443\H,3.4846411761,0.,1.8437423773\H,3.3210379443,0.,-0.6 
 412202033\H,1.1001538185,0.,-1.7347988936\C,-1.3025437611,0.,-0.585033 
 8796\C,-2.544757744,0.,-0.0509745077\H,-1.2315654148,0.,-1.6746930639\ 
 C,-3.7273303853,0.,-0.9135582026\H,-2.7315685261,0.,1.0201983024\O,-4. 
 8798497167,0.,-0.5081965743\H,-3.5176191337,0.,-2.0063642731\\Version= 
 EM64L-G03RevE.01\State=1-A'\HF=-422.9953337\RMSD=9.955e-09\RMSF=1.935e 
 -05\Thermal=0.\Dipole=1.9675194,0.,0.0161028\PG=CS [SG(C9H8O1)]\\@ 
  
17, X = COOMe  
1\1\GINC-V1257\FOpt\RB3LYP\Gen\C10H10O2\JMH502\22-Oct-2012\0\\#B3LYP/g 
 en 6D INT(grid=ultrafine) OPT IOP(2/17=4) Freq=noraman 
 maxdisk=262144000\\meo-dienophile.a2.freq\\0,1\C,-0.0568095831,0.,0.15 
 39806611\C,0.1192030325,0.,1.5526533555\C,1.3953096355,0.,2.1095798187 
 \C,2.5274114944,0.,1.2846284521\C,2.3711524675,0.,-0.1034466023\C,1.09 
 17580884,0.,-0.6606262285\H,-0.7466318282,0.,2.2085510619\H,1.51072631 
 07,0.,3.1904279658\H,3.5217725036,0.,1.7234239674\H,3.2432761814,0.,-0 
 .7520375516\H,0.9733917023,0.,-1.7418507797\C,-1.371778403,0.,-0.49149 
 98435\C,-2.5816600072,0.,0.1023383845\H,-1.3646056408,0.,-1.5810972077 
 \C,-3.8130148347,0.,-0.7112101162\H,-2.7136941481,0.,1.1796187731\O,-3 
 .8732136702,0.,-1.9291851961\O,-4.9138700359,0.,0.0833950251\C,-6.1790 
 798991,0.,-0.5992415626\H,-6.9324328767,0.,0.1891723536\H,-6.274260244 
 7,0.8912779056,-1.2257008652\H,-6.2742602447,-0.8912779056,-1.22570086 
 52\\Version=EM64L-G09RevA.02\State=1-A'\HF=-537.5534476\RMSD=6.687e-09 
 \RMSF=8.357e-05\Dipole=0.4094065,0.,0.7496465\Quadrupole=9.1843168,-5. 
 7494471,-3.4348697,0.,-1.7454724,0.\PG=CS [SG(C10H8O2),X(H2)]\\@ 
 
17, X = COOEt  
1\1\GINC-V1273\FOpt\RB3LYP\Gen\C11H12O2\JMH502\22-Oct-2012\0\\#B3LYP/g 
 en 6D INT(grid=ultrafine) OPT IOP(2/17=4) Freq=noraman 
 maxdisk=262144000\\eto-dienophile.a2.global.freq\\0,1\C,-0.10162945,0. 
 ,0.1418276683\C,0.1123673626,0.,1.5352812671\C,1.4030566227,0.,2.05758 
 31085\C,2.512459711,0.,1.2023454413\C,2.3185726265,0.,-0.1809455986\C, 
 1.0245575452,0.,-0.7033808495\H,-0.7354934204,0.,2.2142095494\H,1.5476 
 95064,0.,3.1349240724\H,3.5183806145,0.,1.6139833654\H,3.172849673,0., 
 -0.8528990589\H,0.8769739952,0.,-1.7810106509\C,-1.4338151997,0.,-0.46 
 76491127\C,-2.626947913,0.,0.1585689676\H,-1.456834658,0.,-1.557047015 
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 6\C,-3.8817531331,0.,-0.6203529658\H,-2.7297977777,0.,1.2392376423\O,- 
 3.9719675127,0.,-1.8367933122\O,-4.9589682294,0.,0.2046997777\C,-6.257 
 5732826,0.,-0.4337458771\C,-7.3082361785,0.,0.661340653\H,-6.330960470 
 4,0.8846591957,-1.074865295\H,-6.3309604704,-0.8846591957,-1.074865295 
 \H,-8.3084083308,0.,0.2122415983\H,-7.2160995941,-0.8884785981,1.29542 
 04599\H,-7.2160995941,0.8884785981,1.2954204599\\Version=EM64L-G09RevA 
 .02\State=1-A'\HF=-576.8731192\RMSD=5.931e-09\RMSF=1.659e-05\Dipole=0. 
 3270667,0.,0.7837774\Quadrupole=10.3219293,-6.1433115,-4.1786178,0.,-1 
 .7183739,0.\PG=CS [SG(C11H8O2),X(H4)]\\@ 
 
17, X = COOCH2CF3  
1\1\GINC-V1280\FOpt\RB3LYP\Gen\C11H9F3O2\JMH502\22-Oct-2012\0\\#B3LYP/ 
 gen 6D INT(grid=ultrafine) OPT IOP(2/17=4) Freq=noraman 
 maxdisk=262144000\\cf3eto-dienophile.a2.global.freq\\0,1\C,-0.10597786 
 44,0.,0.1489573233\C,0.1164207957,0.,1.5413073614\C,1.410658703,0.,2.0 
 538142773\C,2.5134159649,0.,1.1897886152\C,2.3108191346,0.,-0.19231898 
 41\C,1.0134491039,0.,-0.7055916011\H,-0.7264007274,0.,2.2263528581\H,1 
 .563546843,0.,3.1298461632\H,3.5221231057,0.,1.5943622767\H,3.16062756 
 62,0.,-0.8696609589\H,0.8580456679,0.,-1.7820560709\C,-1.4406034612,0. 
 ,-0.4504547748\C,-2.6303438756,0.,0.1853491083\H,-1.4703300956,0.,-1.5 
 396642578\C,-3.8813592685,0.,-0.5866170378\H,-2.7286755958,0.,1.265964 
 872\O,-4.0007026814,0.,-1.797899421\O,-4.963587941,0.,0.252082391\C,-6 
 .2319028487,0.,-0.3937687673\C,-7.2935729678,0.,0.6915448765\H,-6.3566 
 719549,0.8903775336,-1.0166196854\H,-6.3566719549,-0.8903775336,-1.016 
 6196854\F,-8.5203008794,0.,0.1115912822\F,-7.2182773841,-1.0897798076, 
 1.4857709192\F,-7.2182773841,1.0897798076,1.4857709192\\Version=EM64L- 
 G09RevA.02\State=1-A'\HF=-874.6121058\RMSD=5.655e-09\RMSF=1.100e-05\Di 
 pole=1.5236707,0.,0.167744\Quadrupole=5.1911122,-3.823625,-1.3674873,0 
 .,3.7577159,0.\PG=CS [SG(C11H7F1O2),X(H2F2)]\\@ 
 
17, X = COOtBu 
1\1\GINC-V1292\FOpt\RB3LYP\Gen\C13H16O2\JMH502\22-Oct-2012\0\\#B3LYP/g 
 en 6D INT(grid=ultrafine) OPT IOP(2/17=4) Freq=noraman 
 maxdisk=262144000\\tbuo-dienophile.a2.global.freq\\0,1\C,-0.0716381767 
 ,0.,0.1672657784\C,0.2132377672,0.,1.5479482657\C,1.5289158178,0.,2.00 
 39001579\C,2.5935066454,0.,1.0935077289\C,2.3292835523,0.,-0.278102396 
 8\C,1.0102354193,0.,-0.7339350536\H,-0.5991511736,0.,2.2689305607\H,1. 
 7280417261,0.,3.0725462101\H,3.6190719404,0.,1.4534634935\H,3.14825178 
 85,0.,-0.9927012516\H,0.8079992652,0.,-1.8026542665\C,-1.4335726932,0. 
 ,-0.373390542\C,-2.5928527927,0.,0.3128328381\H,-1.5126977181,0.,-1.46 
 01549801\C,-3.8894951393,0.,-0.4027349285\H,-2.639326372,0.,1.39731322 
 64\O,-4.0207626394,0.,-1.6161881662\O,-4.9080658414,0.,0.4889704209\C, 
 -6.3237417647,0.,0.0674105871\C,-7.0698069704,0.,1.4048128974\C,-6.635 
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 0340177,1.2737831142,-0.7268846685\C,-6.6350340177,-1.2737831142,-0.72 
 68846685\H,-8.1516494195,0.,1.2309046327\H,-6.8130565019,-0.8881935582 
 ,1.9922416457\H,-6.8130565019,0.8881935582,1.9922416457\H,-7.713825392 
 9,1.3288702352,-0.9156599551\H,-6.3457494252,2.162140432,-0.1536831871 
 \H,-6.1123977731,1.2858983222,-1.6852839419\H,-7.7138253929,-1.3288702 
 352,-0.9156599551\H,-6.1123977731,-1.2858983222,-1.6852839419\H,-6.345 
 7494252,-2.162140432,-0.1536831871\\Version=EM64L-G09RevA.02\State=1-A 
 '\HF=-655.5049961\RMSD=1.892e-09\RMSF=1.197e-05\Dipole=0.2483293,0.,0. 
 7014221\Quadrupole=10.4770191,-6.7467768,-3.7302423,0.,-1.009475,0.\PG 
 =CS [SG(C11H8O2),X(C2H8)]\\@ 
 
 
Binding Studies by NMR Spectroscopy 
 
The construct of the dengue virus NS2B-NS3 protease used in this work was described 
previously.[14] The protein was expressed in vivo in the E. coli strain Rosetta:: λDE3/pRARE using 
a high-cell density method.[15] The pelleted cells were re-suspended in 50 mL lysis buffer A (50 
mM HEPES, pH 7.5, 300 mM NaCl), disrupted by French press lysis at 12000 psi and centrifuged 
at 16000 × g for 45 min. at 4°C to remove the cell debris. The supernatant was filtered (Sartorius 
0.45 µm filter) and loaded onto a 5-mL HisTrap HP column (GE Healthcare) equilibrated with 
buffer A. After washing the column with 20 mL buffer A at a flow rate of 1 mL/min, a gradient 
from 15–500 mM imidazole was applied over 60 min. The dengue virus protease eluted at 200 mM 
imidazole. Fractions containing the protease were pooled, dialyzed against NMR buffer (20 mM 
Tris, pH 6.9, 50 mM NaCl) and loaded onto a 50 mL Toyopearl DEAE-650M column equilibrated 
with the same buffer. After washing the column with 50 mL of NMR buffer, a gradient from 50 
mM to 1 M NaCl was applied over 200 mL. The dengue virus protease eluted at 300 mM NaCl. 
Fractions containing the dengue virus protease were pooled, dialyzed against NMR buffer and 
concentrated in a centrifugal filter device (Millipore, MWCO 10000) for NMR experiments. 
 
All NMR spectra were recorded at 25°C on a Bruker 800 MHz NMR spectrometer equipped with a 
cryoprobe. 0.1 mM samples of the dengue virus protease were prepared in NMR buffer (20 mM 
Tris, pH 6.9, 50 mM NaCl). In different experiments, panduratin A 1 and 4-hydroxypanduratin A 2 
were individually added in equimolar ratio and in five-fold molar excess to the protein from a 100 
mM stock solution in DMSO-d6.  
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